arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Ensysce Biosciences, Inc.

ENSC

$0.52 ▲ +0.17 (+48.69%) at close

9 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Ensysce Biosciences, Inc. faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.3M

Dividend Yield —

Revenue Growth -2.8% ↘

Op. Margin -202.1% ↘

ROIC -251.7% ↘

FCF / Share $-3.10 ↗

Trailing P/E —

Price / Book 0.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 6, 2026.

9-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$5.07M

↓ -2.8% —

Net Income Profit after all expenses

$-10.18M

↓ -27.4% —

Operating Margin Operating profit as % of sales

-202.1%

↓ -56.5% 0th

FCF / Share Free cash flow per share

$-3.10

↑ +71.2% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Revenue Growth YoY (%)	-2.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-134%)	133.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1570%)	-11.6% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-245%)	-28.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-457%)	-10.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-227%)	—	—	—	—
EPS Growth YoY (%)	65.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-144.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	96.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-370.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-27.4% Weak ↓ Weak Declining Year-over-year change in net income	24.8% Good ↑ Good Improving Year-over-year change in net income	56.1% Excellent ↑ Excellent Improving Year-over-year change in net income	16.9% Good ↑ Good Improving Year-over-year change in net income	-18017.1% Weak Weak Year-over-year change in net income	N/M	-82.8% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	71.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-125.9% Weak ↑ Weak Improving Year-over-year change in free cash flow	95.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-1116.1% Weak Weak Year-over-year change in free cash flow	-10234.6% Weak Weak Year-over-year change in free cash flow	—	—	—	—
Revenue CAGR 3Y (%)	26.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	13.8% Good Good Compound annual revenue growth over 3 years	-17.2% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—
Revenue CAGR 5Y (%)	5.2% Fair Fair Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Operating Margin (%) (%)	-202.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1447%)	-129.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-961%)	-480.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3303%)	—	—	-41.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-374%)	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	—	—	60.3% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	20.7% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-200.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1774%)	-153.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1378%)	-476.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4070%)	—	—	-4.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-134%)	—	—	—
FCF Margin (%) (%)	-156.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-144.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-483.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	—	-233.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-31.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.28x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	7.75x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-3.89x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.58x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Return on Invested Capital (%)	-251.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-143.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2622.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	515.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	199.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	19.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-15.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-137.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-120.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-395.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-411.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-121.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-458.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-1.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-0.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	—	-215.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1536%)	—	—	—	2.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-83%)	7.3% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-51%)	42.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+183%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Interest Coverage (x)	-1606.42x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-760.64x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-30.28x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-221.16x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-15.34x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1.62x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-4.31M	$-3.50M	$-1.12M	$-3.15M	$-12.26M	$-194.21K	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Revenue per Share (USD)	$1.98	$7.47	$0.99	$14.02	$3.50	$0.25	—	—	—
Basic EPS, GAAP (USD)	$-3.98	$-11.45	$-4.69	$-139.42	$-29.64	$0.00	—	—	—
Free Cash Flow per Share (USD)	$-3.10	$-10.75	$-4.76	$-99.42	$-8.17	$-0.08	—	—	—
Book Value per Share (USD)	$0.70	$2.74	$-0.10	$-6.95	$-6.39	$-0.41	$0.78	$0.83	$0.74
Tangible Book Value per Share (USD)	$0.70	$2.74	$-0.10	$-6.95	$-6.39	$-0.41	$0.78	$0.83	$0.74
Basic Weighted Avg Shares (shares)	2.56M	697,686	2.26M	179,925	1.01M	15.77M	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Working Capital (USD)	$2.67M	$3.14M	$-1.04M	$-4.17M	$-819.07K	$-6.66M	$-1.57M	$1.48M	$2.15M
Total Equity (USD)	$3.21M	$3.71M	$-322.86K	$-3.71M	$-7.88M	$-6.44M	$5.00M	$5.00M	$5.00M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Sales/Revenue/Turnover (USD)	$5.07M	$5.21M	$2.23M	$2.52M	$3.53M	$3.93M	—	—	—
Depreciation Expense (USD)	$6.53K	$0.00	$0.00	$0.00	$151.00	$201.00	—	—	—
Net Income, GAAP (USD)	$-10.18M	$-7.99M	$-10.63M	$-24.21M	$-29.15M	$-160.88K	$365.95K	$2.12M	—
Operating Cash Flow (USD)	$-7.81M	$-7.50M	$-10.78M	$-17.89M	$-8.24M	$-1.25M	$-1.42M	$-1.24M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 35 quarters

Ensysce Biosciences, Inc.

Analytical Summary

9-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ENSC with peers